Organon (OGN) Tops Q2 EPS by 6c ; Offers Guidance

Organon (NYSE: OGN) reported Q2 EPS of $1.00, $0.06 better than the analyst estimate of $0.94. Revenue for the quarter came in at $1.59 billion versus the consensus estimate of $1.56 billion.

GUIDANCE:

Organon sees FY2025 revenue of $6.27-6.37 billion, versus the consensus of $6.22 billion.

For earnings history and earnings-related data on Organon (OGN) click here.

You May Also Be Interested In

• INVO Fertility (IVF) Tops Q2 EPS by 105c
• Centuri reports $475M+ in new contract awards for 2026
• Cloudastructure reports 164% subscription revenue growth in Q2 2026